1 / 30

Biochemical markers for the prediction of preterm birth

Biochemical markers for the prediction of preterm birth. American Journal of Obstetrics and Gynecology 2005 May, S36-46 산부인과 조인호. Introduction. Preterm birth is the most responsible for poor pregnancy outcome in the US and many other developed countries. 70% of neonatal death.

tallis
Télécharger la présentation

Biochemical markers for the prediction of preterm birth

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Biochemical markers for the prediction of preterm birth American Journal of Obstetrics and Gynecology 2005 May, S36-46 산부인과 조인호

  2. Introduction • Preterm birth is the most responsible for poor pregnancy outcome in the US and many other developed countries. • 70% of neonatal death. • ½ of preterm birth : long-term neurologic disability • Definition: before 37wks of GA -> spontaneous onset of labor or rupture of the fetal membranes.

  3. Reasons of Prediction of preterm labor • Initiate appropriate risk-specific treatment • Define a population of women who are at risk, -> we can study a particular treatment. • Being able to predict the Preterm labor which ma allow us to gain important insights

  4. Source of biologic fluid • Amniotic fluid, urine, cervical mucus, vaginal secretion, serum or plasma, saliva • Consideration • Biologically plausible • Ease of collection • Costs • Safety

  5. Timing • Time that the sample is collected. • ALP, ferritine in plasma level • <20wks of gestation : little value in the prediction of a preterm labor • 24wks of gestation : highly predictive of preterm birth. • Fetal fibronection • >24wks of gestation : less predictive value

  6. Timing • Matrix metalloproteinase-9 • 24 hours before the Initiation of Labor or PPROM -> turn positive • The time between test turn positive and the beginning of labor or PPROM is so little.

  7. Timing • Bacterial vaginosis : strong predictor of of prematurity ->sufficiently early in gestational age and intervention. • Fetal fibronectin test : 22-24wks of gestation • The time of day of the sample collection may also be important. • Salivary estriol predicts late preterm births quite well, but 36wks birth is not important.

  8. Predictive value • Any preterm predictive test and positive prdictive values generally should be high for the test to be useful. • Some investigators have found negative predictive value (ie, the ability to predict who will not haver a preterm birth) to be useful and cost saving. • Fetal fibronectin : high negative predictive value

  9. Classification of types of biologic marker • Placental proteins • A-fetoprotein, major basic protein, placental isoferritin • Placental protein hormones • CRH, adrenocorticotropin, prolactin, hCG • Non-protein hormones • Estrogens, progestines • Non-hormonal proteins • ALP, ferritin in placental site or extrauterine sites

  10. Infection-related factors • In the last decade, it has become clear Infection/inflammation has a strong association with preterm delivery. • Define markers of inflammation: • C-reative protein : ferritin, interleukins, chemokines, cytokines, defensins, bacteria and bacterial products.

  11. y

  12. Cervical and vaginal fluid • Many of substances have been found in cervical or vaginal fluids for their ability to predict spontaneous preterm birth. • Gonococcus, Chlamydia, group B- streptococcus, herpes virus … • Baterial vaginosis : 2-fold increased risk of spontaneous preterm birth. • Associated with an increased risk for intrauterine infection.

  13. Cervical and vaginal fluid • Various cytokines associated with preterm birth. • IL-6, monocyte chemotactic protein 1, IGF binding protein 1, WBC, collagen synthesis and degradation • Fetal fibronectin • Produced by fetal membranes and trophoblasts • Before 20wks : not found in the cervix and vagina (>50ng/mL) • 22-24wks : positive이면 very powerful predictor • 24wks : postive이면 4wks 후 preterm birth가 올 확률이 60배 증가

  14. Amniotic fluid • Generally is not obtained from asymptomatic women • GA 16-18wks • Increased IL-6 • Wenstrom et al : associated with fetal loss within next 4wks • Presence of Ureaplasma • Symptomatic women • Marker of infection in amniotic fluid • Various cytokines [IL-1, IL-6, TNF-a], WBC, defensins, various metalloproteinases, low glucose levels

  15. Urine • Various hormones and various organisms -> useful marker • Urine DNA examination (Chlamydia, gonorrhea) -> prediction of vaginal or cervical colonization

  16. Saliva • Ultrafiltrate of plasma • Easiest fluid to collect • Recently, estriol has potential relationship to preterm labor • Unconjugated steroid hormones -> saliva (diffusion) • But, estriol was better marker for late preterm labor • Limitation • Patient activity/posture, food consumtion • Oral lesions, abrasions, gingivitis

  17. Serum/Plasma • Over the last several decades, hundreds of publications have attempted to evaluate various plasma (or serum) components for predict preterm birth • G-CSF, ferritin level (strongest) • High a-fetoprotein, ALP, high CRH (useful marker)

  18. Multiple markers • Powerful predictor • A-fetoprotein, ALP, G-CSF (maternal serum) • Fetal fibronectin (cervicovaginal mucus) • Cervical length (ultrasound) • Several biologic markers together might be useful.

  19. Genomics/Proteomics • Genomics • Gene expression -> mRNA • Relation • Host genome, gene expression, phenotype • Proteomics • Complete protein complement, proteome • Relation • Disease, phenotype of interest

  20. Genomics/Proteomics • Genetic study • Single nucleotide polymorphism relate on preterm birth • But, results have been inconsistent • Research tools (available) • Gene array chips, gene sequencing • Protein array chips, mass spectrometry • Now, these technique has only begun to explored to idendifiy gene/protein

  21. Clinical utility • Identification of biomarkers • Insights into the pathophysiologic condition of these pregnancy complication • Identify highest risk women for targeted interventions. • But, few markers have high test sensitivity, specificity, and positive predictive value • Few interventions have shown to be of benefit to prevent or reduce the incidence of preterm birth

  22. Clinical utility • Scenario • Increased cervical/vaginal fetal fibronectin (biomarker) -> Antibiotics (intervention) • Failed to prevent subsequent preterm birth.

  23. Clinical utility • Recently, • Progesterone use to reduce preterm birth. • Target : Hx. of preterm birth/not biologic fluid marker • So, define that populaton that is appropriate for treatment • But, the other various markers haver the potential to better. • In addintion, mid-trimester : maternal serum progesterone이 상승.-> preterm birth의 marker

  24. Comment • The goal of the study • Understand pathways that lead to preterm birth • To define a high-risk population for future intervention studies • To select a population in which a specific prevention intervention is to be used, or occasionally • To select a population that is at low risk so that they may be spared various interventions.

  25. Comment • Only use of marker for routine prenatal care (single or multiple marker test) -> significant reduction in preterm birth

More Related